Recombinant Neorudin for the Prevention of Deep-Vein Thrombosis After Spinal-Cord Injury

References

• Mackiewicz-Milewska M, Jung S, Kroszczyński AC, et al. Deep venous thrombosis in patients with chronic spinal cord injury. J Spinal Cord Med. 2016;39(4):400–404. doi:10.1179/2045772315y.0000000032
   PubMed Web of Science ®Google Scholar
• Dahl OE, Caprini JA, Colwell CW Jr, et al. Fatal vascular outcomes following major orthopedic surgery. Thromb Haemost. 2005;93(5):860–866. doi:10.1160/th04-11-0769
   PubMed Web of Science ®Google Scholar
• Teasell RW, Hsieh JT, Aubut JA, et al. Venous thromboembolism after spinal cord injury. Arch Phys Med Rehabil. 2009;90(2):232–245. doi:10.1016/j.apmr.2008.09.557
   PubMed Web of Science ®Google Scholar
• Rojas-Tomba F, Gormaz-Talavera I, Menéndez-Quintanilla IE, et al. [Incidence and risk factors of venous thromboembolism in major spinal surgery with no chemical or mechanical prophylaxis]. Rev Esp Cir Ortop Traumatol. 2016;60(2):133–140. Spanish. doi:10.1016/j.recot.2015.10.002
   PubMedGoogle Scholar
• Smith MD, Bressler EL, Lonstein JE, et al. Deep venous thrombosis and pulmonary embolism after major reconstructive operations on the spine. A prospective analysis of three hundred and seventeen patients. J Bone Joint Surg Am. 1994;76(7):980–985. doi:10.2106/00004623-199407000-00004
   PubMedGoogle Scholar
• Brohi K, Cohen MJ, Ganter MT, et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma. 2008;64(5):1211–7; discussion 1217. doi:10.1097/TA.0b013e318169cd3c
   PubMedGoogle Scholar
• Christie S, Thibault-Halman G, Casha S. Acute pharmacological DVT prophylaxis after spinal cord injury. J Neurotrauma. 2011;28(8):1509–1514. doi:10.1089/neu.2009.1155-A
   PubMed Web of Science ®Google Scholar
• Chen HL, Wang XD. Heparin for venous thromboembolism prophylaxis in patients with acute spinal cord injury: a systematic review and meta-analysis. Spinal Cord. 2013;51(8):596–602. doi:10.1038/sc.2013.48
   PubMed Web of Science ®Google Scholar
• Zhang HR, Xu MY, Yang XG, et al. Nomogram for predicting the postoperative venous thromboembolism in spinal metastasis tumor: a multicenter retrospective study. Front Oncol. 2021;11(629823). doi:10.3389/fonc.2021.629823
   Google Scholar
• Dibiasi C, Gratz J, Wiegele M, et al. Anti-factor Xa activity is not associated with venous thromboembolism in critically Ill patients receiving enoxaparin for thromboprophylaxis: a retrospective observational study. Front Med. 2022;9(888451). doi:10.3389/fmed.2022.888451
   Google Scholar
• Chung SB, Lee SH, Kim ES, et al. Incidence of deep vein thrombosis after spinal cord injury: a prospective study in 37 consecutive patients with traumatic or nontraumatic spinal cord injury treated by mechanical prophylaxis. J Trauma. 2011;71(4):867–70; discussion 870–1. doi:10.1097/TA.0b013e31822dd3be
   Google Scholar
• Nanclares BVC, Padilla-Zambrano HS, El-Menyar A, et al. WACEM consensus paper on deep venous thrombosis after traumatic spinal cord injury. J Emerg Trauma Shock. 2019;12(2):150–154. doi:10.4103/jets.Jets_125_18
   PubMed Web of Science ®Google Scholar
• Bernsen RA, Hoogenraad TU. A spinal haematoma occurring in the subarachnoid as well as in the subdural space in a patient treated with anticoagulants. Clin Neurol Neurosurg. 1992;94(1):35–37. doi:10.1016/0303-8467(92)90116-k
   PubMed Web of Science ®Google Scholar
• Piran S, Schulman S. Incidence and risk factors for venous thromboembolism in patients with acute spinal cord injury: a retrospective study. Thromb Res. 2016;147:97–101. doi:10.1016/j.thromres.2016.09.030
   PubMed Web of Science ®Google Scholar
• Marciniak CM, Kaplan J, Welty L, et al. Enoxaparin versus tinzaparin for venous thromboembolic prophylaxis during rehabilitation after acute spinal cord injury: a retrospective cohort study comparing safety and efficacy. PMR. 2012;4(1):11–17. doi:10.1016/j.pmrj.2011.10.007
   PubMedGoogle Scholar
• Gerlach R, Raabe A, Beck J, et al. Postoperative nadroparin administration for prophylaxis of thromboembolic events is not associated with an increased risk of hemorrhage after spinal surgery. Eur Spine J. 2004;13(1):9–13. doi:10.1007/s00586-003-0642-8
   PubMed Web of Science ®Google Scholar
• Bono CM, Watters WC 3rd, Heggeness MH, et al. An evidence-based clinical guideline for the use of antithrombotic therapies in spine surgery. Spine J. 2009;9(12):1046–1051. doi:10.1016/j.spinee.2009.09.005
   PubMed Web of Science ®Google Scholar
• Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149(2):315–352. doi:10.1016/j.chest.2015.11.026
   PubMed Web of Science ®Google Scholar
• Rogers FB, Cipolle MD, Velmahos G, et al. Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the EAST practice management guidelines work group. J Trauma. 2002;53(1):142–164. doi:10.1097/00005373-200207000-00032
   PubMedGoogle Scholar
• Zhang C, Yu A, Yuan B, et al. Construction and functional evaluation of hirudin derivatives with low bleeding risk. Thromb Haemost. 2008;99(2):324–330. doi:10.1160/th07-07-0453
   PubMed Web of Science ®Google Scholar
• Greinacher A, Lubenow N. Recombinant hirudin in clinical practice: focus on lepirudin. Circulation. 2001;103(10):1479–1484. doi:10.1161/01.cir.103.10.1479
   PubMed Web of Science ®Google Scholar
• Dong X, Gu R, Zhu X, et al. Evaluating prodrug characteristics of a novel anticoagulant fusion protein neorudin, a prodrug targeting release of hirudin variant 2-Lys47 at the thrombosis site, by means of in vitro pharmacokinetics. Eur J Pharm Sci. 2018;121:166–177. doi:10.1016/j.ejps.2018.05.025
   PubMed Web of Science ®Google Scholar
• Dong X, Meng Z, Gu R, et al. Predicting the metabolic characteristics of neorudin, a novel anticoagulant fusion protein, in patients with deep vein thrombosis. Thromb Res. 2020;194:121–134. doi:10.1016/j.thromres.2020.05.048
   PubMed Web of Science ®Google Scholar
• Liu YB, Zhou XC, Liu Y, et al. Inhibitory role of recombinant neorudin on canine coronary artery thrombosis. Pharmacol Res Perspect. 2022;10(3):e00956. doi:10.1002/prp2.956
   PubMed Web of Science ®Google Scholar
• Liu YB, Zhang L, Zhou XC, et al. The antithrombotic effect of recombinant neorudin on thrombi. Drug Des Devel Ther. 2022;16:1667–1678. doi:10.2147/dddt.S353088
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang M, Dong X, et al. A Phase I, single and continuous dose administration study on the safety, tolerability, and pharmacokinetics of neorudin, a novel recombinant anticoagulant protein, in healthy subjects. Pharmacol Res Perspect. 2021;9(3):e00785. doi:10.1002/prp2.785
   PubMed Web of Science ®Google Scholar
• Li S, Zhou J, Zhang J, et al. Construction of rat spinal cord injury model based on Allen’s animal model. Saudi J Biol Sci. 2019;26(8):2122–2126. doi:10.1016/j.sjbs.2019.09.033
   PubMed Web of Science ®Google Scholar
• Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma. 1995;12(1):1–21. doi:10.1089/neu.1995.12.1
   PubMed Web of Science ®Google Scholar
• Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I9–16. doi:10.1161/01.Cir.0000078469.07362.E6
   PubMed Web of Science ®Google Scholar
• Arnold PM, Harrop JS, Merli G, et al. Efficacy, safety, and timing of anticoagulant thromboprophylaxis for the prevention of venous thromboembolism in patients with acute spinal cord injury: a systematic review. Global Spine J. 2017;7(3 Suppl):138s–150s. doi:10.1177/2192568217703665
   PubMedGoogle Scholar
• Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e278S–e325S. doi:10.1378/chest.11-2404
   PubMed Web of Science ®Google Scholar
• Green D. Prophylaxis of thromboembolism in spinal cord-injured patients. Chest. 1992;102(6 Suppl):649s–651s. doi:10.1378/chest.102.6_supplement.649s
   PubMed Web of Science ®Google Scholar
• Alabed S, Belci M, Van Middendorp JJ, et al. Thromboembolism in the sub-acute phase of spinal cord injury: a systematic review of the literature. Asian Spine J. 2016;10(5):972–981. doi:10.4184/asj.2016.10.5.972
   PubMedGoogle Scholar
• Matsumoto S, Suda K, Iimoto S, et al. Prospective study of deep vein thrombosis in patients with spinal cord injury not receiving anticoagulant therapy. Spinal Cord. 2015;53(4):306–309. doi:10.1038/sc.2015.4
   PubMed Web of Science ®Google Scholar
• Hull RD. Venous thromboembolism in spinal cord injury patients. Chest. 1992;102(6 Suppl):658s–663s. doi:10.1378/chest.102.6_supplement.658s
   PubMed Web of Science ®Google Scholar
• Aito S, Pieri A, D’Andrea M, et al. Primary prevention of deep venous thrombosis and pulmonary embolism in acute spinal cord injured patients. Spinal Cord. 2002;40(6):300–303. doi:10.1038/sj.sc.3101298
   PubMed Web of Science ®Google Scholar
• Piran S, Schulman S. Thromboprophylaxis in patients with acute spinal cord injury: a narrative review. Semin Thromb Hemost. 2019;45(2):150–156. doi:10.1055/s-0039-1678720
   PubMed Web of Science ®Google Scholar
• Zeeshan M, Khan M, O’Keeffe T, et al. Optimal timing of initiation of thromboprophylaxis in spine trauma managed operatively: a nationwide propensity-matched analysis of trauma quality improvement program. J Trauma Acute Care Surg. 2018;85(2):387–392. doi:10.1097/ta.0000000000001916
   PubMed Web of Science ®Google Scholar